Microbiome Therapeutics Global Market Report 2022 – By Product (Probiotics, Prebiotics, Symbiotics, and Other Products), By Application (Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, and Other Applications), By Distribution Channel (Hospital Pharmacies, Drug Stores, Retail Pharmacies, and E-commerce Stores) – Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 175 | Published : August 2022 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

The microbiome therapeutics market consists of sales of microbiome therapeutics and related services by entities (organizations, sole traders, partnership) which are used to treat and prevent various diseases. The microbiome comprises the genetic material within a microbiota which is an entire collection of microorganisms found in and on all multicellular organisms.

The main products of microbiome therapeutics are probiotics, prebiotics, symbiotics, and other products. Probiotics are a combination of live beneficial bacteria and/or yeasts that naturally live in the body. The various distribution channels involved are hospital pharmacies, drug stores, retail pharmacies, and e-commerce stores. The applications included are inflammatory bowel disease, diabetes, multiple sclerosis, rheumatoid arthritis, and other applications.

The global microbiome therapeutics market size is expected to grow from $0.29 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 34.7%. The global microbiome therapeutics market size is expected to grow to $1 billion in 2026 at a compound annual growth rate (CAGR) of 26.4%.

The rising prevalence of obesity is expected to propel the growth of the microbiome therapeutics market. Sedentary lifestyles, busy work lives, and unhealthy food choices are gradually becoming the leading causes of obesity globally. Growing urbanization and busy lifestyles are leading to an increasing preference for packaged and processed foods and physical inactivity. Microbiome therapeutics help prevent and treat diabetes by regulating sugar levels. For instance, in 2022, according to the UK Parliament, a survey found that men are more likely than women to be overweight or obese (68.2% of men, 60.4% of women). People aged 45–74 are most likely to be overweight or obese. Therefore, the rising prevalence of obesity is driving the growth of microbiome therapeutics.

Increased research and development is a key trend gaining popularity in the microbiome therapeutics market. Companies operating in the microbiome therapeutics market are focused on developing new innovations to increase their market share. For instance, in March 2022, Microbiotica, a UK-based company, raised $67 million in a Series B round to push two microbiome-based lead assets through phase 1b trials, slated to start this year.

In April 2022, Xbiome Inc., a China-based artificial intelligence microbiome therapeutics startup, acquired a clinical-stage M201 program from Assembly Biosciences, Inc. for an undisclosed amount. This acquisition reflects Xbiome’s commitment as one of the leaders in the rising field of microbiome therapeutics. Assembly Biosciences, Inc. is a US-based clinical-stage biotechnology company.

Major players in the microbiome therapeutics market are Seres Therapeutics, Enterome Bioscience, Rebiotix, Microbiome Therapeutics, and Ritter Pharmaceuticals.

North America was the largest region in the microbiome therapeutics market in 2021. The regions covered in the global microbiome therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the microbiome therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA.

The global microbiome therapeutics market is segmented -

1) By Product: Probiotics, Prebiotics, Symbiotics, and Others

2) By Application: Inflammatory Bowel Disease, Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, and Others

3) By Distribution Channel: Hospital Pharmacies, Drug stores, Retail Pharmacies, and E-commerce stores

    Table Of Contents

    1. Executive Summary

    2. Microbiome Therapeutics Market Characteristics

    3. Microbiome Therapeutics Market Size And Growth

    3.1. Global Microbiome Therapeutics Historic Market, 2016 - 2021, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Microbiome Therapeutics Forecast Market, 2021-2026F, 2031F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Microbiome Therapeutics Market Segmentation

    4.1. Global Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Probiotics

    Prebiotics

    Symbiotics

    Other Products

    4.2. Global Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Inflammatory Bowel Disease

    Diabetes

    Multiple Sclerosis

    Rheumatoid Arthritis

    Others

    4.3. Global Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospital Pharmacies

    Drug stores

    Retail Pharmacies

    E-commerce stores

    5. Microbiome Therapeutics Market Regional And Country Analysis

    5.1. Global Microbiome Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    5.2. Global Microbiome Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    6. Asia-Pacific Microbiome Therapeutics Market

    6.1. Asia-Pacific Microbiome Therapeutics Market Overview

    6.2. Asia-Pacific Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    6.3. Asia-Pacific Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    6.4. Asia-Pacific Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7. China Microbiome Therapeutics Market

    7.1. China Microbiome Therapeutics Market Overview

    7.2. China Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    7.3. China Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    7.4. China Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    8. India Microbiome Therapeutics Market

    8.1. India Microbiome Therapeutics Market Overview

    8.2. India Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.3. India Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8.4. India Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. Japan Microbiome Therapeutics Market

    9.1. Japan Microbiome Therapeutics Market Overview

    9.2. Japan Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9.3. Japan Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9.4. Japan Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10. Australia Microbiome Therapeutics Market

    10.1. Australia Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.2. Australia Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    10.3. Australia Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Indonesia Microbiome Therapeutics Market

    11.1. Indonesia Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.2. Indonesia Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11.3. Indonesia Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. South Korea Microbiome Therapeutics Market

    12.1. South Korea Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.2. South Korea Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12.3. South Korea Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Western Europe Microbiome Therapeutics Market

    13.1. Western Europe Microbiome Therapeutics Market Overview

    13.2. Western Europe Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.3. Western Europe Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13.4. Western Europe Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. UK Microbiome Therapeutics Market

    14.1. UK Microbiome Therapeutics Market Overview

    14.2. UK Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.3. UK Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14.4. UK Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Germany Microbiome Therapeutics Market

    15.1. Germany Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.2. Germany Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15.3. Germany Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. France Microbiome Therapeutics Market

    16.5. France Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.6. France Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16.7. France Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Eastern Europe Microbiome Therapeutics Market

    17.1. Eastern Europe Microbiome Therapeutics Market Overview

    17.2. Eastern Europe Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.3. Eastern Europe Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17.4. Eastern Europe Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. Russia Microbiome Therapeutics Market

    18.1. Russia Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.2. Russia Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18.3. Russia Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. North America Microbiome Therapeutics Market

    19.1. North America Microbiome Therapeutics Market Overview

    19.2. North America Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.3. North America Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19.4. North America Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. USA Microbiome Therapeutics Market

    20.1. USA Microbiome Therapeutics Market Overview

    20.2. USA Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.3. USA Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20.4. USA Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. South America Microbiome Therapeutics Market

    21.1. South America Microbiome Therapeutics Market Overview

    21.2. South America Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.3. South America Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21.4. South America Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. Brazil Microbiome Therapeutics Market

    22.1. Brazil Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.2. Brazil Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22.3. Brazil Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. Middle East Microbiome Therapeutics Market

    23.1. Middle East Microbiome Therapeutics Market Overview

    23.2. Middle East Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.3. Middle East Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23.4. Middle East Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Africa Microbiome Therapeutics Market

    24.1. Africa Microbiome Therapeutics Market Overview

    24.2. Africa Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.3. Africa Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24.4. Africa Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Microbiome Therapeutics Market Competitive Landscape And Company Profiles

    25.1. Microbiome Therapeutics Market Competitive Landscape

    25.2. Microbiome Therapeutics Market Company Profiles

    25.2.1. Seres Therapeutics

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Enterome Bioscience

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Rebiotix

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. MicroBiome Therapeutics

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Ritter Pharmaceuticals

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Microbiome Therapeutics Market

    27. Microbiome Therapeutics Market Trends And Strategies

    28. Microbiome Therapeutics Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 4: Global Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 5: Global Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 6: Global Microbiome Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 7: Global Microbiome Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 9: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 10: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 11: China, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 12: China, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 13: China, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 14: India, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 15: India, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 16: India, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 17: Japan, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 18: Japan, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 19: Japan, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 20: Australia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 21: Australia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 22: Australia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 23: Indonesia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 24: Indonesia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 25: Indonesia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 26: South Korea, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 27: South Korea, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 28: South Korea, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 29: Western Europe, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 30: Western Europe, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 31: Western Europe, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 32: UK, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 33: UK, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 34: UK, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 35: Germany, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 36: Germany, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 37: Germany, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 38: France, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 39: France, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 40: France, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 41: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 42: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 43: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 44: Russia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 45: Russia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 46: Russia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 47: North America, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 48: North America, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 49: North America, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 50: USA, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 51: USA, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 52: USA, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 53: South America, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 54: South America, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 55: South America, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 56: Brazil, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 57: Brazil, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 58: Brazil, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 59: Middle East, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 60: Middle East, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 61: Middle East, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 62: Africa, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 63: Africa, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 64: Africa, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Table 65: Seres Therapeutics Financial Performance
  • Table 66: Enterome Bioscience Financial Performance
  • Table 67: Rebiotix Financial Performance
  • Table 68: MicroBiome Therapeutics Financial Performance
  • Table 69: Ritter Pharmaceuticals Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 4: Global Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 5: Global Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 6: Global Microbiome Therapeutics Market, Split By Region, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 7: Global Microbiome Therapeutics Market, Split By Country, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 9: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 10: Asia-Pacific, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 11: China, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 12: China, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 13: China, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 14: India, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 15: India, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 16: India, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 17: Japan, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 18: Japan, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 19: Japan, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 20: Australia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 21: Australia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 22: Australia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 23: Indonesia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 24: Indonesia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 25: Indonesia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 26: South Korea, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 27: South Korea, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 28: South Korea, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 29: Western Europe, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 30: Western Europe, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 31: Western Europe, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 32: UK, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 33: UK, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 34: UK, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 35: Germany, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 36: Germany, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 37: Germany, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 38: France, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 39: France, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 40: France, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 41: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 42: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 43: Eastern Europe, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 44: Russia, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 45: Russia, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 46: Russia, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 47: North America, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 48: North America, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 49: North America, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 50: USA, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 51: USA, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 52: USA, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 53: South America, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 54: South America, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 55: South America, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 56: Brazil, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 57: Brazil, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 58: Brazil, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 59: Middle East, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 60: Middle East, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 61: Middle East, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 62: Africa, Microbiome Therapeutics Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 63: Africa, Microbiome Therapeutics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 64: Africa, Microbiome Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2026F, 2031F, $ Billion
  • Figure 65: Seres Therapeutics Financial Performance
  • Figure 66: Enterome Bioscience Financial Performance
  • Figure 67: Rebiotix Financial Performance
  • Figure 68: MicroBiome Therapeutics Financial Performance
  • Figure 69: Ritter Pharmaceuticals Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer), And By Region, Opportunities And Strategies – Global Forecast To 2032
View Report
Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor, Frozen Donor), By Application (Male, Female), And By Region, Opportunities And Strategies – Global Forecast To 2032
View Report
Dental Services Market 2022 – By Type (General Dentistry, Oral Surgery, Orthodontics, Prosthodontics), By Type Of Procedure (Cosmetic Dentistry, Non-Cosmetic Dentistry), By End-User (Gender) (Male, Female), By Type Of Expenditure (Public, Private), And By Region, Opportunities And Strategies – Global Forecast To 2031 
View Report
Telehealth Market 2021 - By Type (Software, Services, Hardware), By Mode Of Delivery (Cloud-Based, On-Premise), By Application (Teleradiology, Telepsychiatry, Telepathology, Teledermatology, Telecardiology), By End-User (Healthcare Providers, Patients, Payers) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Medical Billing Outsourcing Global Market Report 2024 – By Service (Front End, Back End), By Component (In-house, Outsourced), By End User (Hospitals, Physician Offices) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Value Based Care Payment Global Market Report 2024 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By End User (Providers, Payer) – Market Size, Trends, And Global Forecast 2024-2033
View Report
IVF Services Global Market Report 2024 – By Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), Donor Egg IVF Cycles), By Service Provider (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes), By End User (Fertility Clinics, Hospitals & Other Settings) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Prenatal Testing & Newborn Screening Global Market Report 2024 – By Diagnostic Type (Non-Invasive, Invasive), By Technology (Screening Technology, Diagnostic Technology), By End user (Hospitals, Diagnostic centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the microbiome therapeutics market?

The microbiome therapeutics market consists of sales of microbiome therapeutics and related services which are used to treat and prevent various diseases such as Type 2 diabetes, Obesity, C. difficile infection and primary hyperoxyurea request a sample here

How will the microbiome therapeutics market drivers and restraints affect microbiome therapeutics market dynamics? What forces will shape the microbiome therapeutics industry going forward?

The microbiome therapeutics market growth is aided by rising prevalence of obesity. However, some microbiome therapeutics market restraints include lack of proper regulations also inhibit investors to invest in microbiome therapeutics request a sample here

What is the forecast market size of the microbiome therapeutics market?

The microbiome therapeutics market forecast is expected to reach $1.28 billion in 2022 at a compound annual growth rate of 14.2%. request a sample here

How is the microbiome therapeutics market segmented?

request a sample here

Which region has largest share, and what is the market size and growth by geography according to the microbiome therapeutics global market report?

For more detail on this, request a sample here.

Who are the key players of the global microbiome therapeutics market?

Top competitors in the microbiome therapeutics market are Seres Therapeutics, Enterome Bioscience, Rebiotix, MicroBiome Therapeutics and Ritter Pharmaceuticals. request a sample here.

What are the key trends in the global microbiome therapeutics market?

Major trends influencing the microbiome therapeutics market include use of phage therapy as their core technology due to its effectiveness in killing disease-causing bacteria in the human body. request a sample here.

What are the major opportunities in the microbiome therapeutics market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global microbiome therapeutics market, request a sample here.

How does the microbiome therapeutics market relate to the overall economy and other similar markets?

request a sample here.

request a sample here.

request a sample here.